SCHEMBL13691762

SCHEMBL13691762

CCC(CN(C)C(=O)[C@H](CCN)NC(C)CNC(=O)c1ccc2ccccc2c1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.44
▸ OPRM1 P35372 2/20 0.41
▸ OPRD1 P41143 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ TMEM97 Q5BJF2 1/20 0.38
▸ SIGMAR1 Q99720 1/20 0.38
▸ CCKBR P32239 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ DRD4 P21917 1/20 0.36
▸ UTS2R Q9UKP6 4/20 0.36
▸ NR1H4 Q96RI1 1/20 0.36
▸ DRD2 P14416 1/20 0.35
▸ DRD3 P35462 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13691793 0.91 NPC1 (0.47) NPC1OPRM1OPRD1RAB9ASMN1; SMN2
SCHEMBL13691761 0.86 DRD3 (0.43) NPC1OPRM1OPRD1RAB9ASMN1; SMN2
SCHEMBL13190966 0.80 HPGD (0.47) NPC1OPRM1OPRD1RAB9ASMN1; SMN2
SCHEMBL13189116 0.80 UTS2R (0.39) NPC1OPRM1TMEM97SIGMAR1KMT2A
SCHEMBL13689525 0.77 DRD3 (0.51) NPC1DRD4DRD2DRD3
SCHEMBL13689520 0.77 DRD3 (0.49) NPC1DRD4DRD2DRD3
SCHEMBL13188836 0.77 NPC1 (0.46) NPC1OPRM1OPRD1RAB9ASMN1; SMN2
SCHEMBL13689398 0.76 NPC1 (0.44) NPC1OPRM1OPRD1RAB9ASMN1; SMN2
SCHEMBL13691765 0.75 NPC1 (0.44) NPC1OPRM1OPRD1RAB9ASMN1; SMN2
SCHEMBL13189113 0.74 UTS2R (0.38) NPC1OPRM1RAB9ASMN1; SMN2TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009105823-A1 3-AMINOALKYL-1,4-DIAZEPAN-2-ONE MELANOCORTIN-5 RECEPTOR ANTAGONISTS MIMETICA PTY LTD (AU) 2009-09-03 — — WO disclosed
Send feedback